ahlam1399
09-26-2015, 06:40 AM
AbbVie scraps Galapagos deal to focus on own arthritis drug
(Reuters) - AbbVie Inc said one of its experimental ***** improved symptoms of rheumatoid arthritis in mid-stage studies and scrapped plans to buy rights to a similar treatment from Belgium's Galapagos NV .
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a2d83d1/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VTrtCLn2LFs:uoDZAwqU8Jo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VTrtCLn2LFs:uoDZAwqU8Jo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/VTrtCLn2LFs
(Reuters) - AbbVie Inc said one of its experimental ***** improved symptoms of rheumatoid arthritis in mid-stage studies and scrapped plans to buy rights to a similar treatment from Belgium's Galapagos NV .
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a2d83d1/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VTrtCLn2LFs:uoDZAwqU8Jo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VTrtCLn2LFs:uoDZAwqU8Jo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=VTrtCLn2LFs:uoDZAwqU8Jo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/VTrtCLn2LFs